                            stdClass Object
(
    [post_id] => 1292
    [category_id] => 4
    [id] => 4
    [language_code] => en
    [title] => News
    [description] => News
    [slug] => news
    [meta_title] => News
    [meta_description] => News
    [meta_keyword] => News
    [content] => 
    [parent_id] => 0
    [thumbnail] => 
    [banner] => trang_chu/tt_xn/gioi_thieu_ttxn_gentis_(10).jpg
    [is_featured] => 
    [files] => 
    [style] => 
    [class] => 
    [type] => post
    [order] => 1
    [is_status] => 1
    [created_time] => 2019-08-24 10:39:48
    [updated_time] => 2021-09-07 13:05:32
    [created_by] => 
    [updated_by] => 
    [ratting] => 
    [retionship] => 
    [question] => 
    [url_video] => 
    [link] => 
    [i_con] => 
)
1

GENTIS Accompanies the 2025 Clinical Embryology Conference

Created date : 24-03-2025

Updated date: 15-04-2025

Author: Gentis

Clinical embryology and issues related to the IVF lab play a vital role in the advancement of Assisted Reproductive Technology (ART). The 6th Clinical Embryology Conference (CEC), organized by the Ho Chi Minh City Society for Reproductive Medicine (HOSREM), will be held on March 22–23, 2025. The conference aims to provide opportunities for professional updates, knowledge exchange, and the presentation of scientific research in the field of clinical embryology. GENTIS is honored to be a sponsor of this important event.

At the conference, leading experts in IVF will present and discuss various issues related to clinical embryology and IVF laboratories. Some of the key topics covered include:

Quality management and new techniques

Embryo genetic testing

Sperm-related factors

Poor prognosis cases

Embryo culture and cryopreservation

Embryos from abnormal fertilization and abnormal oocytes

Notably, GENTIS is proud to have provided PGT-M testing data for the presentation by Resident Doctor Lê Thảo Ly (Quang Ninh Obstetrics and Pediatrics Hospital), titled: "Evaluating the Live Birth Rate Following Preimplantation Genetic Testing for Monogenic Disorders (PGT-M) for Thalassemia at Quang Ninh Obstetrics and Pediatrics Hospital from 2022–2024."

According to Dr. Thảo Ly, Thalassemia is the most common autosomal recessive inherited anemia worldwide, including in Vietnam. This disease significantly impacts the physical and mental well-being of patients and their families. While there is currently no definitive cure, it can be proactively prevented and screened. Importantly, the introduction of PGT-M has helped reduce the risk of giving birth to children affected by Thalassemia.

At GENTIS, the PGT-M test is conducted using cutting-edge technologies and modern equipment, including Veriseq PGS, next-generation sequencing (NGS) with Illumina technology (USA), and SNP/STR analysis methods. This ensures the high reliability of test results. Currently, GENTIS is capable of screening for more than 100 monogenic diseases using PGT-M.

As a sponsor of the conference, GENTIS presented an impressive booth with a variety of engaging activities, drawing great interest from many delegates. Highlights included:

Introducing advanced, modern solutions for preimplantation embryo genetic screening tailored to improve healthcare outcomes for the Vietnamese population, particularly two new PGT testing packages: PGT NEXT and PGT UPGRADE

Providing the latest genetic testing materials in the field of assisted reproduction

Offering attractive appreciation gifts to participating delegates

Over the years, GENTIS has regularly participated in conferences and seminars to stay updated with the latest insights, technologies, and advancements in IVF. Our goal is to provide effective and accurate genetic testing for patients.

The 2025 Clinical Embryology Conference concluded successfully, offering a wealth of knowledge, clinical expertise, and updates on trends, technologies, and treatment protocols. It also signals promising growth in Vietnam’s reproductive health sector in the years ahead.